Catalent Commences Construction of New $20M Expansion to Its Clinical Supply Facility in Schorndorf, Germany
April 07, 2023
April 07, 2023
SOMERSET, New Jersey, April 7 -- Catalent Inc., a pharma, biotech and consumer health company, issued the following news on April 6, 2023:
Catalent, the leader in enabling the development and supply of better treatments for patients worldwide, today announced that it has begun construction of a $20 million expansion project at its clinical supply facility in Schorndorf, Germany. A ground-breaking ceremony was recently attended by the Mayor of Schorndorf, Bernd Hornikel, as well as l . . .
Catalent, the leader in enabling the development and supply of better treatments for patients worldwide, today announced that it has begun construction of a $20 million expansion project at its clinical supply facility in Schorndorf, Germany. A ground-breaking ceremony was recently attended by the Mayor of Schorndorf, Bernd Hornikel, as well as l . . .